Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 156

Similar articles for PubMed (Select 24117128)

1.

Pro-apoptotic TP53 homolog TAp63 is repressed via epigenetic silencing and B-cell receptor signalling in chronic lymphocytic leukaemia.

Humphries LA, Godbersen JC, Danilova OV, Kaur P, Christensen BC, Danilov AV.

Br J Haematol. 2013 Dec;163(5):590-602. doi: 10.1111/bjh.12580. Epub 2013 Sep 30.

2.

PKCδ stabilizes TAp63 to promote cell apoptosis.

Li D, Li C, Wu M, Chen Q, Wang Q, Ren J, Zhang Y.

FEBS Lett. 2015 Jun 23. pii: S0014-5793(15)00471-8. doi: 10.1016/j.febslet.2015.06.014. [Epub ahead of print]

PMID:
26112605
3.

Establishment and Characterization of PCL12, a Novel CD5+ Chronic Lymphocytic Leukaemia Cell Line.

Agathangelidis A, Scarfò L, Barbaglio F, Apollonio B, Bertilaccio MT, Ranghetti P, Ponzoni M, Leone G, De Pascali V, Pecciarini L, Ghia P, Caligaris-Cappio F, Scielzo C.

PLoS One. 2015 Jun 25;10(6):e0130195. doi: 10.1371/journal.pone.0130195. eCollection 2015.

4.

Small nucleolar RNA expression profiles refine the prognostic impact of IGHV mutational status on treatment-free survival in chronic lymphocytic leukaemia.

Berquet L, Valleron W, Grgurevic S, Quelen C, Zaki O, Quillet-Mary A, Davi F, Brousset P, Bousquet M, Ysebaert L.

Br J Haematol. 2015 Jun 11. doi: 10.1111/bjh.13544. [Epub ahead of print] No abstract available.

PMID:
26095450
5.

The splicing modulator sudemycin induces a specific antitumor response and cooperates with ibrutinib in chronic lymphocytic leukemia.

Xargay-Torrent S, López-Guerra M, Rosich L, Montraveta A, Roldán J, Rodríguez V, Villamor N, Aymerich M, Lagisetti C, Webb TR, López-Otín C, Campo E, Colomer D.

Oncotarget. 2015 Jun 8. [Epub ahead of print]

6.

VIII. Treatment of chronic lymphocytic leukaemia, where are we heading?

O'Brien SM.

Hematol Oncol. 2015 Jun;33 Suppl 1:46-9. doi: 10.1002/hon.2216. No abstract available.

PMID:
26062054
7.

Factors involved in CLL pathogenesis and cell survival are disrupted by differentiation of CLL B-cells into antibody-secreting cells.

Ghamlouch H, Darwiche W, Hodroge A, Ouled-Haddou H, Dupont S, Singh AR, Guignant C, Trudel S, Royer B, Gubler B, Marolleau JP.

Oncotarget. 2015 May 11. [Epub ahead of print]

8.

Notch signaling sustains the expression of Mcl-1 and the activity of eIF4E to promote cell survival in CLL.

De Falco F, Sabatini R, Del Papa B, Falzetti F, Di Ianni M, Sportoletti P, Baldoni S, Screpanti I, Marconi P, Rosati E.

Oncotarget. 2015 May 12. [Epub ahead of print]

9.

The SIRT1/TP53 axis is activated upon B-cell receptor triggering via miR-132 up-regulation in chronic lymphocytic leukemia cells.

Dal Bo M, D'Agaro T, Gobessi S, Zucchetto A, Dereani S, Rossi D, Zaja F, Pozzato G, Di Raimondo F, Gaidano G, Laurenti L, Del Poeta G, Efremov DG, Gattei V, Bomben R.

Oncotarget. 2015 May 11. [Epub ahead of print]

10.

Acidosis Sensing Receptor GPR65 Correlates with Anti-Apoptotic Bcl-2 Family Member Expression in CLL Cells: Potential Implications for the CLL Microenvironment.

Rosko AE, McColl KS, Zhong F, Ryder CB, Chang MJ, Sattar A, Caimi PF, Hill BT, Al-Harbi S, Almasan A, Distelhorst CW.

J Leuk (Los Angel). 2014 Dec;2(5). pii: 160.

11.

The pre-B-cell receptor checkpoint in acute lymphoblastic leukaemia.

Eswaran J, Sinclair P, Heidenreich O, Irving J, Russell LJ, Hall A, Calado DP, Harrison CJ, Vormoor J.

Leukemia. 2015 May 6. doi: 10.1038/leu.2015.113. [Epub ahead of print] Review.

PMID:
25943180
12.

Chronic lymphocytic leukaemia induces an exhausted T cell phenotype in the TCL1 transgenic mouse model.

Gassner FJ, Zaborsky N, Catakovic K, Rebhandl S, Huemer M, Egle A, Hartmann TN, Greil R, Geisberger R.

Br J Haematol. 2015 May 4. doi: 10.1111/bjh.13467. [Epub ahead of print]

PMID:
25940792
13.

The regulatory interaction of EVI1 with the TCL1A oncogene impacts cell survival and clinical outcome in CLL.

Vasyutina E, Boucas JM, Bloehdorn J, Aszyk C, Crispatzu G, Stiefelhagen M, Breuer A, Mayer P, Lengerke C, Döhner H, Beutner D, Rosenwald A, Stilgenbauer S, Hallek M, Benner A, Herling M.

Leukemia. 2015 May 4. doi: 10.1038/leu.2015.114. [Epub ahead of print]

PMID:
25936528
14.

B cells generated by B-1 development can progress to chronic lymphocytic leukemia.

Hayakawa K, Formica AM, Colombo MJ, Ichikawa D, Shinton SA, Brill-Dashoff J, Hardy RR.

Ann N Y Acad Sci. 2015 Apr 23. doi: 10.1111/nyas.12768. [Epub ahead of print]

PMID:
25907284
15.

Role of microRNA in chronic lymphocytic leukemia onset and progression.

Balatti V, Pekarky Y, Croce CM.

J Hematol Oncol. 2015 Feb 20;8(1):12. doi: 10.1186/s13045-015-0112-x.

16.

Pathogenesis of chronic lymphocytic leukemia.

Fukuda T.

Rinsho Ketsueki. 2015;56(3):261-8. doi: 10.11406/rinketsu.56.261.

PMID:
25876778
17.

Targeting the spliceosome in chronic lymphocytic leukemia with the macrolides FD-895 and pladienolide-B.

Kashyap MK, Kumar D, Villa R, La Clair JJ, Benner C, Sasik R, Jones H, Ghia EM, Rassenti LZ, Kipps TJ, Burkart MD, Castro JE.

Haematologica. 2015 Jul;100(7):945-54. doi: 10.3324/haematol.2014.122069. Epub 2015 Apr 10.

18.

Genetic and epigenetic profiling of CLL disease progression reveals limited somatic evolution and suggests a relationship to memory-cell development.

Smith EN, Ghia EM, DeBoever CM, Rassenti LZ, Jepsen K, Yoon KA, Matsui H, Rozenzhak S, Alakus H, Shepard PJ, Dai Y, Khosroheidari M, Bina M, Gunderson KL, Messer K, Muthuswamy L, Hudson TJ, Harismendy O, Barrett CL, Jamieson CH, Carson DA, Kipps TJ, Frazer KA.

Blood Cancer J. 2015 Apr 10;5:e303. doi: 10.1038/bcj.2015.14.

19.

Association between gene and miRNA expression profiles and stereotyped subset #4 B-cell receptor in chronic lymphocytic leukemia.

Maura F, Cutrona G, Mosca L, Matis S, Lionetti M, Fabris S, Agnelli L, Colombo M, Massucco C, Ferracin M, Zagatti B, Reverberi D, Gentile M, Recchia AG, Bossio S, Rossi D, Gaidano G, Molica S, Cortelezzi A, Di Raimondo F, Negrini M, Tassone P, Morabito F, Ferrarini M, Neri A.

Leuk Lymphoma. 2015 May 18:1-9. [Epub ahead of print]

PMID:
25860243
20.

Mechanisms of ibrutinib resistance in chronic lymphocytic leukaemia and non-Hodgkin lymphoma.

Zhang SQ, Smith SM, Zhang SY, Lynn Wang Y.

Br J Haematol. 2015 Apr 9. doi: 10.1111/bjh.13427. [Epub ahead of print]

PMID:
25858358
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk